These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 33642117)

  • 1. Lineage-associated connexin 43 expression in bisphosphonate-exposed rat bones.
    Preidl RHM; Amann K; Weber M; Schiller M; Ringler M; Ries J; Neukam FW; Kesting M; Geppert CI; Wehrhan F
    J Craniomaxillofac Surg; 2021 Aug; 49(8):738-747. PubMed ID: 33642117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rescue bisphosphonate treatment of alveolar bone improves extraction socket healing and reduces osteonecrosis in zoledronate-treated mice.
    Hokugo A; Kanayama K; Sun S; Morinaga K; Sun Y; Wu Q; Sasaki H; Okawa H; Evans C; Ebetino FH; Lundy MW; Sadrerafi K; McKenna CE; Nishimura I
    Bone; 2019 Jun; 123():115-128. PubMed ID: 30926440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential modulation of zoledronate and etidronate in osseous healing of an extracted socket and tibia defect.
    Lim SS; Lee B; Kim IS; Hwang SJ
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Jan; 123(1):8-19. PubMed ID: 27727104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in macrophage polarization in the craniofacial and extracranial skeleton after zoledronate application and surgical interventions - an
    Struckmeier AK; Wehrhan F; Preidl R; Mike M; Mönch T; Eilers L; Ries J; Trumet L; Lutz R; Geppert C; Kesting M; Weber M
    Front Immunol; 2023; 14():1204188. PubMed ID: 37292209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microarchitecture of medication-related osteonecrosis of the jaw (MRONJ); a retrospective micro-CT and morphometric analysis.
    Schoenhof R; Munz A; Yuan A; ElAyouti A; Boesmueller H; Blumenstock G; Reinert S; Hoefert S
    J Craniomaxillofac Surg; 2021 Jun; 49(6):508-517. PubMed ID: 33707134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is bone turnover of jawbone and its possible over suppression by bisphosphonates of etiologic importance in pathogenesis of bisphosphonate-related osteonecrosis?
    Ristow O; Gerngroß C; Schwaiger M; Hohlweg-Majert B; Kehl V; Jansen H; Hahnefeld L; Otto S; Pautke C
    J Oral Maxillofac Surg; 2014 May; 72(5):903-10. PubMed ID: 24485975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Commentary--Is the bone turnover of the jawbone and its possible over suppression by bisphosphonates of etiological importance for the pathogenesis of the bisphosphonate-related osteonecrosis?
    Carlson ER; Gerard DA
    J Oral Maxillofac Surg; 2014 May; 72(5):911-3. PubMed ID: 24480759
    [No Abstract]   [Full Text] [Related]  

  • 8. BRONJ-related jaw bone is associated with increased Dlx-5 and suppressed osteopontin-implication in the site-specific alteration of angiogenesis and bone turnover by bisphosphonates.
    Wehrhan F; Amann K; Möbius P; Weber M; Preidl R; Ries J; Stockmann P
    Clin Oral Investig; 2015 Jul; 19(6):1289-98. PubMed ID: 25467232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiresorptive Agent-Related Osteonecrosis of the Jaw (ARONJ): A Twist of Fate in the Bone.
    Shibahara T
    Tohoku J Exp Med; 2019 Feb; 247(2):75-86. PubMed ID: 30713280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zoledronate induces osteonecrosis of the jaw in sheep.
    Voss PJ; Stoddart M; Ziebart T; Zeiter S; Nelson K; Bittermann G; Schmelzeisen R; Poxleitner P
    J Craniomaxillofac Surg; 2015 Sep; 43(7):1133-8. PubMed ID: 26154396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of medication-related osteonecrosis of jaw: Comparison between icariin and teriparatide in a rat model.
    Liu J; Mattheos N; Deng C; Su C; Wang Z; Luo N; Tang H
    J Periodontol; 2021 Jan; 92(1):149-158. PubMed ID: 32281098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of concentrated growth factor (CGF) in the surgical treatment of medication-related osteonecrosis of the jaw (MRONJ) in osteoporosis patients: a randomized controlled study.
    Yüce MO; Adalı E; Işık G
    Clin Oral Investig; 2021 Jul; 25(7):4529-4541. PubMed ID: 33392802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histologic analysis of medication-related osteonecrosis of the jaw compared with antiresorptive-exposed bone and other infectious, inflammatory, and necrotic jaw diseases.
    Yuan A; Munz A; Reinert S; Hoefert S
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Feb; 129(2):133-140. PubMed ID: 31606424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.
    Baba A; Goto TK; Ojiri H; Takagiwa M; Hiraga C; Okamura M; Hasegawa S; Okuyama Y; Ogino N; Yamauchi H; Kobashi Y; Yamazoe S; Munetomo Y; Mogami T; Nomura T
    Dentomaxillofac Radiol; 2018 May; 47(4):20170323. PubMed ID: 29365278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Strategy against the Osteonecrosis of the Jaw Associated with Nitrogen-Containing Bisphosphonates (N-BPs): Attempts to Replace N-BPs with the Non-N-BP Etidronate.
    Oizumi T; Yamaguchi K; Sato K; Takahashi M; Yoshimura G; Otsuru H; Tsuchiya M; Hagiwara Y; Itoi E; Sugawara S; Takahashi T; Endo Y
    Biol Pharm Bull; 2016; 39(9):1549-54. PubMed ID: 27582334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathological Effects of Teriparatide in Medication-Related Osteonecrosis of the Jaw: An Animal Study.
    Keskinruzgar A; Bozdag Z; Aras MH; Demir T; Yolcu U; Cetiner S
    J Oral Maxillofac Surg; 2016 Jan; 74(1):68-78. PubMed ID: 26215490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further development of the MRONJ minipig large animal model.
    Otto S; Pautke C; Martin Jurado O; Nehrbass D; Stoddart MJ; Ehrenfeld M; Zeiter S
    J Craniomaxillofac Surg; 2017 Sep; 45(9):1503-1514. PubMed ID: 28803745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Position paper on medication-related osteonecrosis of the jaw (MRONJ)].
    Svejda B; Muschitz Ch; Gruber R; Brandtner Ch; Svejda Ch; Gasser RW; Santler G; Dimai HP
    Wien Med Wochenschr; 2016 Feb; 166(1-2):68-74. PubMed ID: 26847441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Markers of Bone Turnover and Angiogenesis in Patients With Bisphosphonate-Related Osteonecrosis of the Jaw After Discontinuation of Long-Term Intravenous Bisphosphonate Therapy.
    Thumbigere-Math V; Michalowicz BS; Hughes PJ; Basi DL; Tsai ML; Swenson KK; Rockwell L; Gopalakrishnan R
    J Oral Maxillofac Surg; 2016 Apr; 74(4):738-46. PubMed ID: 26501428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progress on medication-related osteonecrosis of the jaw].
    Wang QZ; Liu JY; Pan J
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2018 Oct; 36(5):568-572. PubMed ID: 30465354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.